ARCHIVES

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

This article is from The Cancer Letter archive.

Vol. 33 No. 07 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Issues: Maryland Law Mandates Insurance Coverage Of Patient Care Costs In Clinical Trials

July 3, 1998

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

Flat NIH Budget Threatens Future Of Research, Universities Say.

March 14, 2008

Senate Voices Discontent With NIH, NCI Budget; Gorton Presses Raub On Cancer’s ‘Low Priority’

March 22, 1991

Minority Trial Participation A Matter of Access, Study Says

December 30, 2005

Cancer Incidence Rates For Recent Years Too Optimistic, NCI Researchers Find

October 25, 2002